Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer

por Pozo, Karine, Zahler, Stefan, Ishimatsu, Keisuke, Carter, Angela M., Telange, Rahul, Tan, Chunfeng, Wang, Shuaijun, Pfragner, Roswitha, Fujimoto, Junya, Grubbs, Elizabeth Gardner, Takahashi, Masaya, Oltmann, Sarah C., Bibb, James A.
Publicado 2018